Journal for ImmunoTherapy of Cancer (Nov 2023)
733 Phase 1 study of ultra-high concentration nitric oxide ablation in relapsed or refractory, unresectable, primary, or metastatic cutaneous and subcutaneous malignancies
Abstract
No abstracts available.